The Board of Directors of Jeil Pharmaceutical Co., Ltd. (KOSE:A002620) authorized a share repurchase program on August 31, 2011. Under the program, the company will repurchase up to KRW 2 billion worth own shares pursuant to a trust agreement with Shinhan Investment Corp. The purpose behind the program is to stabilize the stock price and to enhance shareholder value. Repurchases will commence on August 31, 2011 and will continue until February 29, 2012. As of August 31, 2011, the company has 1,478,600 shares under directly owned treasury stock and 284,720 shares in treasury under trust agreement.

On February 28, 2012, the company extended its share repurchase program until August 31, 2012.

On August 30, 2012, the company extended its share repurchase program until February 28, 2013.

Till August 30, 2012, the company has repurchased 436,160 shares. Shinhan Investment Corp. acted as the broker for the buyback.

Jeil Pharmaceutical Co., Ltd.'s share repurchase program expired on February 28, 2013.